Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kiromic Biopharma, Inc. (KRBP) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kiromic Biopharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1792581.
Total stock buying since 2021: $68,951.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 21,799 | $58,594 | 0 | $0 | 0 | $0 |
| 2022 | 0 | $0 | 0 | $0 | 17,240 | $0 |
| 2021 | 2,800 | $10,357 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-08 | 9,488 | $19,707 | 0 | $0 | 0 | $0 |
| 2024-06 | 12,311 | $38,887 | 0 | $0 | 0 | $0 |
| 2022-05 | 0 | $0 | 0 | $0 | 17,240 | $0 |
| 2021-09 | 2,800 | $10,357 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-26 | Bersani Pietro (Chief Executive Officer) | Buy | 988 | 1.93 | 1,906 |
| 2024-08-23 | Bersani Pietro (Chief Executive Officer) | Buy | 2,500 | 2.20 | 5,500 |
| 2024-08-20 | Hungerford Brian (Chief Financial Officer) | Buy | 3,742 | 2.20 | 8,221 |
| 2024-08-19 | Hungerford Brian (Chief Financial Officer) | Buy | 258 | 2.25 | 580 |
| 2024-08-13 | Hungerford Brian (Chief Financial Officer) | Buy | 2,000 | 1.75 | 3,500 |
| 2024-06-13 | Hungerford Brian (CFO) | Buy | 1,000 | 2.60 | 2,600 |
| 2024-06-12 | Misajon Pamela | Buy | 1,610 | 3.27 | 5,264 |
| 2024-06-12 | Hungerford Brian (CFO) | Buy | 1,000 | 3.18 | 3,180 |
| 2024-06-12 | Bersani Pietro (CEO) | Buy | 3,000 | 3.28 | 9,840 |
| 2024-06-11 | Bersani Pietro (CEO) | Buy | 3,000 | 3.23 | 9,690 |
| 2024-06-11 | Nagel Michael | Buy | 1,000 | 3.33 | 3,330 |
| 2024-06-10 | Misajon Pamela | Buy | 1,701 | 2.93 | 4,983 |
| 2022-05-23 | Dahlbeck Scott (Chief Medical Officer) | Option Ex | 17,240 | .00 | 0 |
| 2021-09-09 | Chiriva Internati Maurizio (CHIEF EXECUTIVE OFFICER) | Buy | 2,800 | 3.70 | 10,357 |
Insider trading activities including stock purchases, stock sales, and option exercises of KRBP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kiromic Biopharma, Inc. (symbol KRBP, CIK number 1792581) see the Securities and Exchange Commission (SEC) website.